Department of Urology, Nouvel Hôpital Civil, Hôpitaux Universitaire de Strasbourg, 1 place de l'Hôpital, 67000, Strasbourg, France.
World J Urol. 2021 Oct;39(10):3891-3896. doi: 10.1007/s00345-021-03672-y. Epub 2021 Apr 9.
Artificial urinary sphincter (AUS) implantation in female patients results in high satisfaction rates and high functional outcomes, but implantation can be challenging and explantation of the device is fairly common. The objective of this study was to review outcomes after AUS explantation in women.
This is a retrospective, monocentric study of all women who underwent open or laparoscopic AUS implantation between November 1994 and July 2019, and patients with AUS explantation were included. Management after AUS explantation using descriptive analysis was assessed.
Over a span of 26 years, 111 women had an AUS implanted by a single surgeon. Of these surgeries, 35 explantations in 29 patients were later required: 20 initial AUSs, nine revised AUSs and six reimplanted AUS (rAUSs). The median time to explantation was 15.5 month (± 0.55). After explantation, 13 rAUSs in 10 patients were successful and two attempts failed. The median time between explantation and rAUS was 8 months (± 0.95). At the last follow-up, five patients still had their rAUS and six rAUSs had required explantation after a median time of 6.5 months (± 0.65). Surgery was still possible for 12 patients who did not have a rAUS: three cystectomies, one bladder neck closure with continent urinary diversion, and six mid-urethral slings or adjustable continence therapy balloon implantations. Among the 23 patients who did not need a cystectomy or a bladder neck closure with continent urinary diversion, four were completely dry (17.4%), 11 were improved (47.8%), and eight (34.8%) experienced unchanged incontinence with the post-explantation management. Limitations include retrospective design, heterogeneous management over time and a relatively small population of patients in our cohort.
Reimplantation of an AUS after an explantation seems feasible after at least 6 months. However, the surgery will be more difficult and satisfaction is not guaranteed. Multicenter databases should be created to help surgeons and patients decide on appropriate management strategies after explantation of an AUS.
人工尿道括约肌(AUS)植入女性患者后满意度和功能效果均较高,但植入手术具有一定挑战性,且设备的取出较为常见。本研究旨在回顾女性 AUS 取出后的结果。
这是一项回顾性单中心研究,纳入了 1994 年 11 月至 2019 年 7 月期间由同一位外科医生进行的所有 AUS 植入女性患者,且这些患者均行 AUS 取出术。采用描述性分析评估 AUS 取出后的管理。
在 26 年的时间跨度内,有 111 名女性接受了单外科医生的 AUS 植入手术。其中 29 名患者进行了 35 次 AUS 取出术:20 次初始 AUS 取出术、9 次修正 AUS 取出术和 6 次再植入 AUS(rAUS)取出术。AUS 取出的中位时间为 15.5 个月(±0.55)。AUS 取出后,10 名患者的 13 个 rAUS 成功,2 次尝试失败。AUS 取出与 rAUS 之间的中位时间为 8 个月(±0.95)。末次随访时,5 名患者仍保留 rAUS,6 名 rAUS 患者在中位时间 6.5 个月(±0.65)后需要再次取出。12 名未行 rAUS 患者仍可行手术:3 例行膀胱切除术,1 例行膀胱颈闭合+可控性尿流改道,6 例行中尿道吊带或可调节性控尿治疗球囊植入术。在 23 名不需要行膀胱切除术或膀胱颈闭合+可控性尿流改道的患者中,4 名患者完全干燥(17.4%),11 名患者改善(47.8%),8 名患者(34.8%)在取出后管理中尿失禁无变化。本研究的局限性包括回顾性设计、随时间推移管理方法的异质性以及研究队列中患者数量相对较少。
AUS 取出后至少 6 个月后再次植入 AUS 似乎是可行的。然而,手术难度会增加,且并不能保证满意的效果。应创建多中心数据库,以帮助外科医生和患者在 AUS 取出后决定合适的管理策略。